Search - tctmd.com

Displaying 21 - 38 of 38

Sort: Relevancy | Date

Presentation TCT 2016

TCT 67: Impact of the SYNTAX Score in Patients With Diabetes and Left-Main and/or Multivessel Coronary Disease: A Pooled Analysis of Individual Patient Level Data From the SYNTAX, PRECOMBAT and BEST Trials

Presenter: Sorin J. Brener, Jean-François Tanguay, Rafael Cavalcante

October 31, 2016

Presentation TCT 2016

Mortality of Stenting vs Bypass Surgery According to Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of SYNTAX, PRECOMBAT, and BEST Trials

Presenter: Jung-Min Ahn

October 30, 2016

News Daily News

Patient-Level Data Supports PCI for Some Patients with Unprotected Left Main Disease

Yael L. Maxwell

September 07, 2016

News Daily News

PCI Continues to Carve Out a Share of Unprotected Left Main Disease in the Absence of Definitive Evidence

Todd Neale

June 08, 2016

Presentation TCT 2015

Left Main PCI vs CABG: Fifteen-Year Results From the Asan Medical Center and 5-Year Results From PRECOMBAT

Presenter: Davide Capodanno, Gregg W. Stone, Jung-Min Ahn

October 15, 2015

Presentation TCT 2015

Update of PCI vs CABG for Left Main PCI (Beyond SYNTAX, PRECOMBAT, BEST, and Meta-analysis 2015): What's Different From 3-Vessel Disease?

Presenter: Gary S. Mintz, Seung-Jung Park, Gregg W. Stone

October 11, 2015

News Conference News ACC 2015

ACC-i2 2015: Strategies to Enhance PCI Results, TAVR Highlighted

Todd Neale

March 20, 2015

News Conference News ACC 2015

Outcomes at 5 Years Reinforce Durability of Stenting for Unprotected Left Main Disease

L.A. McKeown

March 15, 2015

News Daily News

Readmissions Higher with PCI vs CABG for Left Main Disease

March 14, 2014

News Daily News

Más Rehospitalizaciones con PCI frente a CABG en el Manejo de la Enfermedad de Tronco Coronario Izdo

March 14, 2014

Presentation TCT 2013

Everolimus-eluting Stents in Left Main Disease: Precombat II 3 Year Results

Presenter: Young-Hak Kim

October 28, 2013

Presentation TCT 2012

Are the Outcomes of Left Main Stenting Improving with Second Generation Stents? Results of PRECOMBAT-2

Presenter: Young-Hak Kim

October 22, 2012

News Daily News

New Revascularization Appropriateness Criteria Feature PCI Upgrades

January 31, 2012

News Conference News

EES Compared Favorably with SES In Two Pivotal Trials

November 08, 2011

News Conference News

Debate: PCI vs. CABG for Left Main Disease

November 07, 2011

News Daily News

Meta-analysis: PCI Equivalent to CABG for Many Left Main Patients

September 19, 2011

News Conference News

ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details

Caitlin E. Cox

April 08, 2011

News Conference News

PRECOMBAT: PCI with Sirolimus Stent Equivalent to CABG in Left Main Disease

April 05, 2011

Advertisement

TCT 67: Impact of the SYNTAX Score in Patients With Diabetes and Left-Main and/or Multivessel Coronary Disease: A Pooled Analysis of Individual Patient Level Data From the SYNTAX, PRECOMBAT and BEST Trials

Mortality of Stenting vs Bypass Surgery According to Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of SYNTAX, PRECOMBAT, and BEST Trials

Patient-Level Data Supports PCI for Some Patients with Unprotected Left Main Disease

PCI Continues to Carve Out a Share of Unprotected Left Main Disease in the Absence of Definitive Evidence

Left Main PCI vs CABG: Fifteen-Year Results From the Asan Medical Center and 5-Year Results From PRECOMBAT

Update of PCI vs CABG for Left Main PCI (Beyond SYNTAX, PRECOMBAT, BEST, and Meta-analysis 2015): What's Different From 3-Vessel Disease?

ACC-i2 2015: Strategies to Enhance PCI Results, TAVR Highlighted

Outcomes at 5 Years Reinforce Durability of Stenting for Unprotected Left Main Disease

Readmissions Higher with PCI vs CABG for Left Main Disease

Más Rehospitalizaciones con PCI frente a CABG en el Manejo de la Enfermedad de Tronco Coronario Izdo

Everolimus-eluting Stents in Left Main Disease: Precombat II 3 Year Results

Are the Outcomes of Left Main Stenting Improving with Second Generation Stents? Results of PRECOMBAT-2

New Revascularization Appropriateness Criteria Feature PCI Upgrades

EES Compared Favorably with SES In Two Pivotal Trials

Debate: PCI vs. CABG for Left Main Disease

Meta-analysis: PCI Equivalent to CABG for Many Left Main Patients

ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details

PRECOMBAT: PCI with Sirolimus Stent Equivalent to CABG in Left Main Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content